Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 388

1.

The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients.

Vidal-Petiot E, Elbez Y, Lüscher TF, Fox KM, Steg PG.

Eur Heart J. 2018 Aug 25. doi: 10.1093/eurheartj/ehy495. [Epub ahead of print] No abstract available.

PMID:
30165378
2.

Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry.

Vidal-Petiot E, Sorbets E, Bhatt DL, Ducrocq G, Elbez Y, Ferrari R, Ford I, Tardif JC, Tendera M, Fox KM, Steg PG; CLARIFY investigators.

Eur Heart J. 2018 Aug 14. doi: 10.1093/eurheartj/ehy488. [Epub ahead of print]

PMID:
30124796
3.

Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.

Telfer P, Agodoa I, Fox KM, Burke L, Mant T, Jurek M, Tonda M, Lehrer-Graiwer J.

Hematol Rep. 2018 May 22;10(2):7643. doi: 10.4081/hr.2018.7643. eCollection 2018 May 14.

4.

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.

Bengtson LGS, DePietro M, McPheeters J, Fox KM.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618772750. doi: 10.1177/1753466618772750.

5.

Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea.

Kim S, Kim H, Kim E, Han S, Rane PP, Fox KM, Zhao Z, Qian Y, Suh HS.

Clin Ther. 2018 Jun;40(6):940-951.e7. doi: 10.1016/j.clinthera.2018.04.007. Epub 2018 May 5.

PMID:
29735297
6.

The Reply.

Kalra PR, Greenlaw N, Ford I, Steg PG, Fox KM.

Am J Med. 2018 Mar;131(3):e129. doi: 10.1016/j.amjmed.2017.09.019. No abstract available.

PMID:
29454433
7.

Characterizing patients with asthma who received Global Initiative for Asthma steps 4-5 therapy and managed in a specialty care setting.

Stone B, Davis JR, Trudo F, Schiffman B, Alzola C, Brown D, Fox KM.

Allergy Asthma Proc. 2018 Jan 1;39(1):27-35. doi: 10.2500/aap.2018.39.4094.

PMID:
29279057
8.

Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy.

Nagar SP, Rane PP, Fox KM, Meyers J, Davis K, Beaubrun A, Inomata H, Qian Y, Kajinami K.

Circ J. 2018 Mar 23;82(4):1008-1016. doi: 10.1253/circj.CJ-17-0811. Epub 2017 Dec 23.

9.

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.

Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U.

Clin Res Cardiol. 2018 May;107(5):380-388. doi: 10.1007/s00392-017-1193-z. Epub 2017 Dec 22.

10.

Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension.

Vidal-Petiot E, Greenlaw N, Ford I, Ferrari R, Fox KM, Tardif JC, Tendera M, Parkhomenko A, Bhatt DL, Steg PG.

Hypertension. 2018 Jan;71(1):168-176. doi: 10.1161/HYPERTENSIONAHA.117.10204. Epub 2017 Oct 30.

PMID:
29084876
11.

Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population.

Davis JR, Wu B, Kern DM, Tunceli O, Fox KM, Horton J, Legg RF, Trudo F.

Am Health Drug Benefits. 2017 Apr;10(2):92-102.

12.

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease.

Sorbets E, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

Clin Cardiol. 2017 Oct;40(10):797-806. doi: 10.1002/clc.22730. Epub 2017 May 31.

13.

Blood pressure and cardiovascular outcomes: a closer look - Authors' reply.

Vidal-Petiot E, Bhatt DL, Fox KM, Steg PG.

Lancet. 2017 Apr 1;389(10076):1296-1297. doi: 10.1016/S0140-6736(17)30835-8. No abstract available.

PMID:
28379150
14.

Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study.

Punekar RS, Fox KM, Paoli CJ, Richhariya A, Cziraky MJ, Gandra SR, Toth PP.

Curr Med Res Opin. 2017 May;33(5):869-876. doi: 10.1080/03007995.2017.1292898. Epub 2017 Mar 9.

PMID:
28276256
15.

Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries.

Abboud H, Sissani L, Labreuche J, Arauz A, Bousser MG, Bryer A, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Lavados PM, Massaro A, Mattle HP, Munoz Collazos M, Rothwell PM, Steg PG, Vicaut E, Yamouth B, Amarenco P; OPTIC Registry and PERFORM Trial Investigators.

Cerebrovasc Dis. 2017;43(3-4):169-177. doi: 10.1159/000454776. Epub 2017 Feb 15.

16.

Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease.

Kalra PR, Greenlaw N, Ferrari R, Ford I, Tardif JC, Tendera M, Reid CM, Danchin N, Stepinska J, Steg PG, Fox KM; ProspeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) Investigators.

Am J Med. 2017 Jun;130(6):720-730. doi: 10.1016/j.amjmed.2017.01.002. Epub 2017 Jan 19.

17.

The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment.

Amarenco P, Sissani L, Labreuche J, Vicaut E, Bousser MG, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle H, Rothwell PM, Steg PG, Diener HC, Sacco RL, Greving JP, Algra A; PERFORM and PRoFESS Committees and Investigators.

Cerebrovasc Dis. 2017;43(3-4):145-151. doi: 10.1159/000453459. Epub 2017 Jan 14.

18.

Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden.

Banefelt J, Hallberg S, Fox KM, Mesterton J, Paoli CJ, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Eur J Health Econ. 2016 Dec;17(9):1117-1124. Epub 2015 Nov 25.

19.

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, Tendera M, Tavazzi L, Bhatt DL, Steg PG; CLARIFY Investigators.

Lancet. 2016 Oct 29;388(10056):2142-2152. doi: 10.1016/S0140-6736(16)31326-5. Epub 2016 Aug 30.

PMID:
27590221
20.

CMR Guidance for Recanalization of Coronary Chronic Total Occlusion.

Bucciarelli-Ducci C, Auger D, Di Mario C, Locca D, Petryka J, O'Hanlon R, Grasso A, Wright C, Symmonds K, Wage R, Asimacopoulos E, Del Furia F, Lyne JC, Gatehouse PD, Fox KM, Pennell DJ.

JACC Cardiovasc Imaging. 2016 May;9(5):547-56. doi: 10.1016/j.jcmg.2015.10.025. Epub 2016 Apr 13.

21.

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.

Oemrawsingh RM, Akkerhuis KM, Van Vark LC, Redekop WK, Rudez G, Remme WJ, Bertrand ME, Fox KM, Ferrari R, Danser AH, de Maat M, Simoons ML, Brugts JJ, Boersma E; PERGENE investigators.

J Am Heart Assoc. 2016 Mar 28;5(3):e002688. doi: 10.1161/JAHA.115.002688.

22.

Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke.

Gonzalez-Valcarcel J, Sissani L, Labreuche J, Bousser MG, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, Steg PG, Vicaut E, Amarenco P; PERFORM Investigators.

Stroke. 2016 Apr;47(4):1045-52. doi: 10.1161/STROKEAHA.115.012091. Epub 2016 Mar 15.

23.

The chemical biology of Cu(II) complexes with imidazole or thiazole containing ligands: Synthesis, crystal structures and comparative biological activity.

Lewis A, McDonald M, Scharbach S, Hamaway S, Plooster M, Peters K, Fox KM, Cassimeris L, Tanski JM, Tyler LA.

J Inorg Biochem. 2016 Apr;157:52-61. doi: 10.1016/j.jinorgbio.2016.01.014. Epub 2016 Jan 11.

PMID:
26828284
24.

Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.

Hallberg S, Banefelt J, Fox KM, Mesterton J, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Int J Clin Pract. 2016 Mar;70(3):222-8. doi: 10.1111/ijcp.12769. Epub 2016 Jan 22.

25.

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.

Fox KM, Wang L, Gandra SR, Quek RGW, Li L, Baser O.

BMC Cardiovasc Disord. 2016 Jan 14;16:13. doi: 10.1186/s12872-016-0190-x.

26.

A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event.

Quek RGW, Fox KM, Wang L, Li L, Gandra SR, Wong ND.

Am J Cardiol. 2016 Feb 15;117(4):495-500. doi: 10.1016/j.amjcard.2015.11.035. Epub 2015 Dec 2.

27.
28.

Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events: a Large United States Real World Study.

Fox KM, Wang L, Quek RG, Gandra SR, Li L, Baser O.

Value Health. 2015 Nov;18(7):A377-8. doi: 10.1016/j.jval.2015.09.792. Epub 2015 Oct 20. No abstract available.

29.

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk.

Quek RG, Fox KM, Wang L, Li L, Gandra SR, Wong ND.

BMJ Open Diabetes Res Care. 2015 Sep 23;3(1):e000132. doi: 10.1136/bmjdrc-2015-000132. eCollection 2015.

30.

Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia.

Punekar RS, Fox KM, Richhariya A, Fisher MD, Cziraky M, Gandra SR, Toth PP.

Clin Cardiol. 2015 Aug;38(8):483-91. doi: 10.1002/clc.22428. Epub 2015 Jun 23.

31.

Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data.

Hallberg S, Gandra SR, Fox KM, Mesterton J, Banefelt J, Johansson G, Levin LÅ, Sobocki P.

Eur J Health Econ. 2016 Jun;17(5):591-601. doi: 10.1007/s10198-015-0702-0. Epub 2015 Jun 16.

32.

The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY.

Ferrari R, Fox KM.

Eur Heart J. 2015 Aug 14;36(31):2042-2046. Epub 2015 Apr 28. No abstract available.

PMID:
25920402
33.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

34.

Heart rate and B-blockade in stable coronary artery disease in Greece.

Sbarouni E, Voudris V, Georgiadou P, Hamilos M, Steg G, Fox KM, Greenlaw N, Vardas PE; Greek CLARIFY investigators.

Hellenic J Cardiol. 2015 Mar-Apr;56(2):112-7.

35.

Hematologic and biochemical reference intervals for adult Friesian horses from North America.

Sample SH, Fox KM, Wunn D, Roth E, Friedrichs KR.

Vet Clin Pathol. 2015 Jun;44(2):194-9. doi: 10.1111/vcp.12248. Epub 2015 Feb 26.

PMID:
25727137
36.

Cardiovascular event rates and healthcare resource utilisation among high-risk adults with type 2 diabetes mellitus in a large population-based study.

Fox KM, Wu Y, Kim J, Grandy S.

Int J Clin Pract. 2015 Feb;69(2):218-27. doi: 10.1111/ijcp.12530.

PMID:
25627336
37.

Serial changes in high-sensitivity cardiac troponin, N-terminal pro-B-type natriuretic peptide, and heart fatty acid binding protein during exercise echocardiography in patients with suspected angina pectoris and normal resting left ventricular function.

de Silva R, Tsujioka H, Gaze D, Banya WA, Shah BN, Zoppelaro G, Hersey J, Gonzalez AM, Collins P, Collinson PO, Senior R, Fox KM.

Clin Chem. 2015 Mar;61(3):554-6. doi: 10.1373/clinchem.2014.228536. Epub 2015 Jan 16. No abstract available.

38.

Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort.

Sbarouni E, Voudris V, Georgiadou P, Hamilos M, Steg PG, Fox KM, Greenlaw N, Ferrari R, Vardas PE.

Hellenic J Cardiol. 2014 Nov-Dec;55(6):442-7.

39.

Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden.

Hallberg S, Banefelt J, Fox KM, Mesterton J, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Value Health. 2014 Nov;17(7):A501. doi: 10.1016/j.jval.2014.08.1507. Epub 2014 Oct 26. No abstract available.

40.

Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden.

Mesterton J, Hallberg S, Gandra SR, Banefelt J, Fox KM, Johansson G, Levin LÅ, Sobocki P.

Value Health. 2014 Nov;17(7):A497. doi: 10.1016/j.jval.2014.08.1486. Epub 2014 Oct 26. No abstract available.

41.

Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden.

Hallberg S, Banefelt J, Mesterton J, Gandra SR, Fox KM, Johansson G, Levin LÅ, Sobocki P.

Value Health. 2014 Nov;17(7):A492. doi: 10.1016/j.jval.2014.08.1455. Epub 2014 Oct 26. No abstract available.

42.

Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden.

Banefelt J, Hallberg S, Gandra SR, Mesterton J, Fox KM, Paoli CJ, Johansson G, Levin LÅ, Sobocki P.

Value Health. 2014 Nov;17(7):A491-2. doi: 10.1016/j.jval.2014.08.1454. Epub 2014 Oct 26. No abstract available.

43.

Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden.

Banefelt J, Hallberg S, Fox KM, Mesterton J, Paoli CJ, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Value Health. 2014 Nov;17(7):A327-8. doi: 10.1016/j.jval.2014.08.596. Epub 2014 Oct 26. No abstract available.

44.

Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.

Steg PG, Greenlaw N, Tendera M, Tardif JC, Ferrari R, Al-Zaibag M, Dorian P, Hu D, Shalnova S, Sokn FJ, Ford I, Fox KM; Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators.

JAMA Intern Med. 2014 Oct;174(10):1651-9. doi: 10.1001/jamainternmed.2014.3773.

PMID:
25110899
45.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

46.

Synthesis, characterization, crystal structures and biological activity of set of Cu(II) benzothiazole complexes: artificial nucleases with cytotoxic activities.

Steiner RA, Foreman D, Lin HX, Carney BK, Fox KM, Cassimeris L, Tanski JM, Tyler LA.

J Inorg Biochem. 2014 Aug;137:1-11. doi: 10.1016/j.jinorgbio.2014.04.002. Epub 2014 Apr 12.

PMID:
24794274
47.

Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke.

Lavallée PC, Labreuche J, Fox KM, Lavados P, Mattle H, Steg PG, Amarenco P; PERFORM, OPTIC, and AMISTAD Investigators.

Neurology. 2014 May 27;82(21):1905-13. doi: 10.1212/WNL.0000000000000456. Epub 2014 Apr 30.

48.

Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.

Sirimarco G, Labreuche J, Bruckert E, Goldstein LB, Fox KM, Rothwell PM, Amarenco P; PERFORM and SPARCL Investigators and Committees.

Stroke. 2014 May;45(5):1429-36. doi: 10.1161/STROKEAHA.113.004229. Epub 2014 Apr 15.

PMID:
24736236
49.

Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample.

Yeaw J, Watson C, Fox KM, Schabert VF, Goodman S, Gandra SR.

Adv Ther. 2014 Apr;31(4):410-25. doi: 10.1007/s12325-014-0110-3. Epub 2014 Mar 7.

PMID:
24604700
50.

Supplemental Content

Loading ...
Support Center